← Return to Clinical Trials: they are not designed only to be a “last resort”

Discussion
Comment receiving replies
@markymarkfl

Thanks very much! I look forward to more news on how your trial is going, as KRAS G12D is next on my targetable mutation list.

Jump to this post


Replies to "Thanks very much! I look forward to more news on how your trial is going, as..."

So sorry to hear that Mark! My oncologist today mentioned that that was one of the most challenging trials. Thanks from everyone here for giving that a try and letting us know of the results!
I wish and pray for your recovery.